Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • USFDA actions hurting...

    USFDA actions hurting exports need govt intervention: Dr Reddy Labs

    Written by savita thakur thakur Published On 2016-04-07T11:50:31+05:30  |  Updated On 7 April 2016 11:50 AM IST

    New Delhi: Asserting that regulatory action by the US Food and Drug Administration (USFDA) on leading Indian firms has impacted exports from the country, Dr Reddy's Laboratories Chairman Satish Reddy asked for a dialogue between government and US health regulator.


    Reddy, who was among the industry leaders who attended the Board of Trade meeting here, said exports have been hit due to USFDA actions.

    Exports of pharma although grew by 9.7 per cent but it used to be in double digits in the past so it has come down slightly, Reddy said.

    "Even though we are growing, we are not growing according to the potential," Reddy said.

    He added that there were several factors that have impacted the exports to the US market, which is the world's largest marketplace for medicines.

    "When it comes to the issue of exports to the US, it has to do more with regulatory actions which the USFDA has had on leading Indian companies which has affected exports.

    "A sustained dialogue that's being carried out by the industry as well as the Commerce Ministry industry is also continuing the dialogue (with the FDA officials). I am not expecting more but just to keep that sustenance of that dialogue. That is critical," he added.

    In the recent times various leading drug makers including Sun Pharma, Lupin, Wockhardt, have come under the scanner of USFDA for lapses in manufacturing norms.

    In November last year, Dr Reddy's had received a warning letter from the USFDA relating to two of its API manufacturing plants and a formulation plant in Andhra Pradesh and Telangana.

    In response to the letter, the country's second-largest drug maker's CEO G V Prasad had said the company is in the process of shifting some of the products from these plants to other facilities and considering third party assessment for its plants.

    The US agency had asked the drug maker to provide a comprehensive evaluation of the extent of inaccuracies in recorded and reported data and include a detailed action plan to fully investigate the scale and root causes of "deficient documentation and data management practices".

    On Venezuela, which has banned drug imports from India, Reddy said: "I would like to point out Venezuela here also we see an opportunity because we are looking at USD 350 million of exports potential going down to zero if we don't act on it."
    Dr Reddy'sG V PrasadLupinSatish ReddySun PharmaUS Food and Drug AdministrationUSFDAWockhardt
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok